3-N-Butylphthalide
Pentoxifylline may increase the antiplatelet activities of Butylphthalide.
Abciximab
Pentoxifylline may increase the antiplatelet activities of Abciximab.
Abiraterone
The serum concentration of Pentoxifylline can be increased when it is combined with Abiraterone.
Advertisement
Acebutolol
Pentoxifylline may increase the hypotensive activities of Acebutolol.
Acenocoumarol
Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.
Acetyl salicylate
Pentoxifylline may increase the antiplatelet activities of Acetylsalicylic acid.
Advertisement
Aliskiren
Pentoxifylline may increase the hypotensive activities of Aliskiren.
Aloxiprin
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Aloxiprin.
alpha Tocopherol
Vitamin E may increase the antiplatelet activities of Pentoxifylline.
Advertisement
Alprenolol
Pentoxifylline may increase the hypotensive activities of Alprenolol.
Alprostadil
Pentoxifylline may increase the antiplatelet activities of Alprostadil.
Alteplase
Pentoxifylline may increase the anticoagulant activities of Alteplase.
Ambrisentan
Pentoxifylline may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Pentoxifylline.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Pentoxifylline.
Aminophylline
The serum concentration of Aminophylline can be increased when it is combined with Pentoxifylline.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Aminosalicylic Acid.
Amlodipine
Pentoxifylline may increase the hypotensive activities of Amlodipine.
Anagrelide
Pentoxifylline may increase the antiplatelet activities of Anagrelide.
Ancrod
Pentoxifylline may increase the anticoagulant activities of Ancrod.
Anistreplase
Pentoxifylline may increase the anticoagulant activities of Anistreplase.
Antithrombin III
Pentoxifylline may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Pentoxifylline may increase the anticoagulant activities of Antithrombin III human.
Apixaban
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Apixaban.
Ardeparin
Pentoxifylline may increase the anticoagulant activities of Ardeparin.
Argatroban
Pentoxifylline may increase the antiplatelet activities of Argatroban.
Argatroban Anhydrous
Pentoxifylline may increase the antiplatelet activities of Argatroban.
Aspirin
Pentoxifylline may increase the antiplatelet activities of Acetylsalicylic acid.
Astaxanthin
Pentoxifylline may increase the anticoagulant activities of Astaxanthin.
Atenolol
Pentoxifylline may increase the hypotensive activities of Atenolol.
Azelastine
Pentoxifylline may increase the antiplatelet activities of Azelastine.
Azithromycin
The metabolism of Pentoxifylline can be decreased when combined with Azithromycin.
Balsalazide
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Balsalazide.
Becaplermin
Pentoxifylline may increase the anticoagulant activities of Becaplermin.
Bemiparin
Pentoxifylline may increase the anticoagulant activities of Bemiparin.
Benazepril
Pentoxifylline may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
Pentoxifylline may increase the hypotensive activities of Bendroflumethiazide.
Bepridil
Pentoxifylline may increase the hypotensive activities of Bepridil.
Betaxolol
Pentoxifylline may increase the hypotensive activities of Betaxolol.
Bethanidine
Pentoxifylline may increase the hypotensive activities of Bethanidine.
Bimatoprost
Pentoxifylline may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Pentoxifylline may increase the hypotensive activities of Bisoprolol.
Bivalirudin
Pentoxifylline may increase the anticoagulant activities of Bivalirudin.
Bortezomib
The metabolism of Pentoxifylline can be decreased when combined with Bortezomib.
Bosentan
Pentoxifylline may increase the hypotensive activities of Bosentan.
Bretylium
Pentoxifylline may increase the hypotensive activities of Bretylium.
Brimonidine
Pentoxifylline may increase the hypotensive activities of Brimonidine.
Bupranolol
Pentoxifylline may increase the hypotensive activities of Bupranolol.
Cafedrine
Pentoxifylline may increase the hypotensive activities of Cafedrine.
Caffeine
The metabolism of Pentoxifylline can be decreased when combined with Caffeine.
Candesartan
Pentoxifylline may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Pentoxifylline may increase the hypotensive activities of Candesartan cilexetil.
Cangrelor
Pentoxifylline may increase the antiplatelet activities of Cangrelor.
Captopril
Pentoxifylline may increase the hypotensive activities of Captopril.
Carteolol
Pentoxifylline may increase the hypotensive activities of Carteolol.
Carvedilol
Pentoxifylline may increase the hypotensive activities of Carvedilol.
Celiprolol
Pentoxifylline may increase the hypotensive activities of Celiprolol.
Certoparin
Pentoxifylline may increase the anticoagulant activities of Certoparin.
Chlorothiazide
Pentoxifylline may increase the hypotensive activities of Chlorothiazide.
Chlorthalidone
Pentoxifylline may increase the hypotensive activities of Chlorthalidone.
Cicletanine
Pentoxifylline may increase the hypotensive activities of Cicletanine.
Cilazapril
Pentoxifylline may increase the hypotensive activities of Cilazapril.
Cilostazol
Pentoxifylline may increase the antiplatelet activities of Cilostazol.
Cimetidine
The serum concentration of Pentoxifylline can be increased when it is combined with Cimetidine.
Citalopram
The metabolism of Pentoxifylline can be decreased when combined with Citalopram.
Citric Acid
Pentoxifylline may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Pentoxifylline may increase the anticoagulant activities of Citric Acid.
Clonidine
Pentoxifylline may increase the hypotensive activities of Clonidine.
Clopidogrel
Pentoxifylline may increase the antiplatelet activities of Clopidogrel.
Clotrimazole
The metabolism of Pentoxifylline can be decreased when combined with Clotrimazole.
COLLAGENASE
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Collagenase clostridium histolyticum.
collagenase Clostridium histolyticum
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Collagenase clostridium histolyticum.
Cryptenamine
Pentoxifylline may increase the hypotensive activities of Cryptenamine.
Cyclopenthiazide
Pentoxifylline may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Pentoxifylline may increase the hypotensive activities of Cyclothiazide.
Cyproterone Acetate
The serum concentration of Pentoxifylline can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
Pentoxifylline may increase the anticoagulant activities of Dabigatran etexilate.
Dalteparin
Pentoxifylline may increase the anticoagulant activities of Dalteparin.
Danaparoid
Pentoxifylline may increase the anticoagulant activities of Danaparoid.
Dasatinib
Dasatinib may increase the anticoagulant activities of Pentoxifylline.
Dasatinib Anhydrous
Dasatinib may increase the anticoagulant activities of Pentoxifylline.
Debrisoquin
Pentoxifylline may increase the hypotensive activities of Debrisoquin.
Deferasirox
The serum concentration of Pentoxifylline can be increased when it is combined with Deferasirox.
Defibrotide
Pentoxifylline may increase the antiplatelet activities of Defibrotide.
Deoxycholate
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Deoxycholic Acid.
Deoxycholic Acid
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Deoxycholic Acid.
Deserpidine
Pentoxifylline may increase the hypotensive activities of Deserpidine.
Desirudin
Pentoxifylline may increase the anticoagulant activities of Desirudin.
Dextran
Pentoxifylline may increase the anticoagulant activities of Dextran.
Dextran 40
Pentoxifylline may increase the anticoagulant activities of Dextran 40.
Dextran 70
Pentoxifylline may increase the anticoagulant activities of Dextran 70.
Dextran 75
Pentoxifylline may increase the anticoagulant activities of Dextran 75.
Diazoxide
Pentoxifylline may increase the hypotensive activities of Diazoxide.
Dicumarol
Pentoxifylline may increase the anticoagulant activities of Dicoumarol.
Diflunisal
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Diflunisal.
Dihydralazine
Pentoxifylline may increase the hypotensive activities of Dihydralazine.
Diltiazem
Pentoxifylline may increase the hypotensive activities of Diltiazem.
Dipyridamole
Pentoxifylline may increase the antiplatelet activities of Dipyridamole.
Dorzolamide
Pentoxifylline may increase the hypotensive activities of Dorzolamide.
Dothiepin
The serum concentration of Pentoxifylline can be increased when it is combined with Dosulepin.
Doxazosin
Pentoxifylline may increase the hypotensive activities of Doxazosin.
Drotrecogin Alfa
Pentoxifylline may increase the anticoagulant activities of Drotrecogin alfa.
Dyphylline
The serum concentration of Dyphylline can be increased when it is combined with Pentoxifylline.
Edetic Acid
Pentoxifylline may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Pentoxifylline may increase the anticoagulant activities of Edoxaban.
Enalapril
Pentoxifylline may increase the hypotensive activities of Enalapril.
Enalaprilat
Pentoxifylline may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Pentoxifylline may increase the hypotensive activities of Enalaprilat.
Enoxaparin
Pentoxifylline may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Pentoxifylline may increase the anticoagulant activities of Enoxaparin.
Epinastine
Pentoxifylline may increase the antiplatelet activities of Epinastine.
Epoprostenol
Pentoxifylline may increase the antiplatelet activities of Epoprostenol.
Eprosartan
Pentoxifylline may increase the hypotensive activities of Eprosartan.
Eptifibatide
Pentoxifylline may increase the antiplatelet activities of Eptifibatide.
Ethylenediaminetetraacetate
Pentoxifylline may increase the anticoagulant activities of Edetic Acid.
Felodipine
Pentoxifylline may increase the hypotensive activities of Felodipine.
Fenoldopam
Pentoxifylline may increase the hypotensive activities of Fenoldopam.
Ferulic Acid
Pentoxifylline may increase the hypotensive activities of Ferulic acid.
Fluindione
Pentoxifylline may increase the anticoagulant activities of Fluindione.
Fluvoxamine
The serum concentration of Pentoxifylline can be increased when it is combined with Fluvoxamine.
Fondaparinux
Pentoxifylline may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Pentoxifylline may increase the anticoagulant activities of Fondaparinux sodium.
Fosinopril
Pentoxifylline may increase the hypotensive activities of Fosinopril.
Glucosamine
Glucosamine may increase the antiplatelet activities of Pentoxifylline.
Guanabenz
Pentoxifylline may increase the hypotensive activities of Guanabenz.
Guanadrel
Pentoxifylline may increase the hypotensive activities of Guanadrel.
Guanethidine
Pentoxifylline may increase the hypotensive activities of Guanethidine.
Guanfacine
Pentoxifylline may increase the hypotensive activities of Guanfacine.
Heparin
Pentoxifylline may increase the anticoagulant activities of Heparin.
Hydralazine
Pentoxifylline may increase the hypotensive activities of Hydralazine.
Hydrochlorothiazide
Pentoxifylline may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Pentoxifylline may increase the hypotensive activities of Hydroflumethiazide.
Hydroxytyrosol
Pentoxifylline may increase the antiplatelet activities of Hydroxytyrosol.
Ibritumomab Tiuxetan
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Ibritumomab tiuxetan.
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Pentoxifylline.
Icosapent Ethyl
Pentoxifylline may increase the antiplatelet activities of Icosapent ethyl.
Ifenprodil
Pentoxifylline may increase the antiplatelet activities of Ifenprodil.
Iloprost
Pentoxifylline may increase the antiplatelet activities of Iloprost.
Imidapril
Pentoxifylline may increase the hypotensive activities of Imidapril.
Indapamide
Pentoxifylline may increase the hypotensive activities of Indapamide.
Indobufen
Pentoxifylline may increase the antiplatelet activities of Indobufen.
Indoramin
Pentoxifylline may increase the hypotensive activities of Indoramin.
Irbesartan
Pentoxifylline may increase the hypotensive activities of Irbesartan.
Isradipine
Pentoxifylline may increase the hypotensive activities of Isradipine.
Ketanserin
Pentoxifylline may increase the antiplatelet activities of Ketanserin.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Pentoxifylline.
Labetalol
Pentoxifylline may increase the hypotensive activities of Labetalol.
Lacidipine
Pentoxifylline may increase the hypotensive activities of Lacidipine.
Latanoprost
Pentoxifylline may increase the hypotensive activities of Latanoprost.
Lepirudin
Pentoxifylline may increase the anticoagulant activities of Lepirudin.
Lercanidipine
Pentoxifylline may increase the hypotensive activities of Lercanidipine.
Lidocaine
The metabolism of Pentoxifylline can be decreased when combined with Lidocaine.
Lisinopril
Pentoxifylline may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Pentoxifylline may increase the hypotensive activities of Lisinopril.
Lofexidine
Pentoxifylline may increase the hypotensive activities of Lofexidine.
Losartan
Pentoxifylline may increase the hypotensive activities of Losartan.
Macitentan
Pentoxifylline may increase the hypotensive activities of Macitentan.
Manidipine
Pentoxifylline may increase the hypotensive activities of Manidipine.
Mecamylamine
Pentoxifylline may increase the hypotensive activities of Mecamylamine.
Mesalamine
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Mesalazine.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Methyl salicylate.
Methyldopa
Pentoxifylline may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Pentoxifylline may increase the hypotensive activities of Methyldopa.
Metipranolol
Pentoxifylline may increase the hypotensive activities of Metipranolol.
Metolazone
Pentoxifylline may increase the hypotensive activities of Metolazone.
Metoprolol
Pentoxifylline may increase the hypotensive activities of Metoprolol.
Metyrosine
Pentoxifylline may increase the hypotensive activities of Metyrosine.
Mexiletine
The serum concentration of Pentoxifylline can be increased when it is combined with Mexiletine.
Mibefradil
Pentoxifylline may increase the hypotensive activities of Mibefradil.
Midostaurin
The serum concentration of Pentoxifylline can be increased when it is combined with Midostaurin.
Milrinone
Pentoxifylline may increase the antiplatelet activities of Milrinone.
Minoxidil
Pentoxifylline may increase the hypotensive activities of Minoxidil.
Moexipril
Pentoxifylline may increase the hypotensive activities of Moexipril.
Moxonidine
Pentoxifylline may increase the hypotensive activities of Moxonidine.
Nadolol
Pentoxifylline may increase the hypotensive activities of Nadolol.
Nadroparin
Pentoxifylline may increase the anticoagulant activities of Nadroparin.
Nebivolol
Pentoxifylline may increase the hypotensive activities of Nebivolol.
Nevirapine
The metabolism of Pentoxifylline can be decreased when combined with Nevirapine.
Nicardipine
Pentoxifylline may increase the hypotensive activities of Nicardipine.
Nicorandil
Pentoxifylline may increase the hypotensive activities of Nicorandil.
Nilvadipine
Pentoxifylline may increase the hypotensive activities of Nilvadipine.
Nimesulide
Pentoxifylline may increase the antiplatelet activities of Nimesulide.
Nimodipine
Pentoxifylline may increase the hypotensive activities of Nimodipine.
Nisoldipine
Pentoxifylline may increase the hypotensive activities of Nisoldipine.
Nitrendipine
Pentoxifylline may increase the hypotensive activities of Nitrendipine.
Nitroprusside
Pentoxifylline may increase the hypotensive activities of Nitroprusside.
Obinutuzumab
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Obinutuzumab.
Olmesartan
Pentoxifylline may increase the hypotensive activities of Olmesartan.
Olsalazine
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Olsalazine.
Omega-3 Fatty Acids
Omega-3 fatty acids may increase the antiplatelet activities of Pentoxifylline.
Osimertinib
The serum concentration of Pentoxifylline can be decreased when it is combined with Osimertinib.
Oxprenolol
Pentoxifylline may increase the hypotensive activities of Oxprenolol.
Pargyline
Pentoxifylline may increase the hypotensive activities of Pargyline.
Parnaparin
Pentoxifylline may increase the anticoagulant activities of Parnaparin.
Peginterferon Alfa-2b
The serum concentration of Pentoxifylline can be increased when it is combined with Peginterferon alfa-2b.
Penbutolol
Pentoxifylline may increase the hypotensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Pentoxifylline may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
The risk or severity of adverse effects can be increased when Pentosan Polysulfate is combined with Pentoxifylline.
Perindopril
Pentoxifylline may increase the hypotensive activities of Perindopril.
Phenindione
Pentoxifylline may increase the anticoagulant activities of Phenindione.
Phenoxybenzamine
Pentoxifylline may increase the hypotensive activities of Phenoxybenzamine.
Phenprocoumon
Pentoxifylline may increase the anticoagulant activities of Phenprocoumon.
Phentolamine
Pentoxifylline may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Pentoxifylline may increase the hypotensive activities of Phentolamine.
Phospholipids
Omega-3 fatty acids may increase the antiplatelet activities of Pentoxifylline.
Pinacidil
Pentoxifylline may increase the hypotensive activities of Pinacidil.
Pindolol
Pentoxifylline may increase the hypotensive activities of Pindolol.
Plasmin
Pentoxifylline may increase the anticoagulant activities of Fibrinolysin.
Polythiazide
Pentoxifylline may increase the hypotensive activities of Polythiazide.
Prasugrel
Pentoxifylline may increase the antiplatelet activities of Prasugrel.
Prazosin
Pentoxifylline may increase the hypotensive activities of Prazosin.
Propranolol
Pentoxifylline may increase the hypotensive activities of Propranolol.
protein C, human
Pentoxifylline may increase the anticoagulant activities of Protein C.
protein S, human
Pentoxifylline may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Pentoxifylline may increase the anticoagulant activities of Protocatechualdehyde.
Quinapril
Pentoxifylline may increase the hypotensive activities of Quinapril.
Ramipril
Pentoxifylline may increase the hypotensive activities of Ramipril.
Rescinnamine
Pentoxifylline may increase the hypotensive activities of Rescinnamine.
Reserpine
Pentoxifylline may increase the hypotensive activities of Reserpine.
Resveratrol
Pentoxifylline may increase the antiplatelet activities of Resveratrol.
Reteplase
Pentoxifylline may increase the anticoagulant activities of Reteplase.
Reviparin
Pentoxifylline may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Pentoxifylline may increase the anticoagulant activities of Reviparin.
Rilmenidine
Pentoxifylline may increase the hypotensive activities of Rilmenidine.
Riociguat
Pentoxifylline may increase the hypotensive activities of Riociguat.
Rivaroxaban
Pentoxifylline may increase the anticoagulant activities of Rivaroxaban.
Ropinirole
The metabolism of Pentoxifylline can be decreased when combined with Ropinirole.
Rosiglitazone
Pentoxifylline may increase the anticoagulant activities of Rosiglitazone.
Rucaparib
The metabolism of Pentoxifylline can be decreased when combined with Rucaparib.
Salicylic Acid
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Salicylic acid.
Selexipag
Pentoxifylline may increase the hypotensive activities of Selexipag.
Sevoflurane
Pentoxifylline may increase the antiplatelet activities of Sevoflurane.
Simeprevir
The metabolism of Pentoxifylline can be decreased when combined with Simeprevir.
Spirapril
Pentoxifylline may increase the hypotensive activities of Spirapril.
Streptokinase
Pentoxifylline may increase the anticoagulant activities of Streptokinase.
Talinolol
Pentoxifylline may increase the hypotensive activities of Talinolol.
Telmisartan
Pentoxifylline may increase the hypotensive activities of Telmisartan.
Tenecteplase
Pentoxifylline may increase the anticoagulant activities of Tenecteplase.
Tenofovir Disoproxil
The metabolism of Pentoxifylline can be decreased when combined with Tenofovir disoproxil.
Teriflunomide
The serum concentration of Pentoxifylline can be decreased when it is combined with Teriflunomide.
Terlipressin
Pentoxifylline may increase the hypotensive activities of Terlipressin.
Theodrenaline
Pentoxifylline may increase the hypotensive activities of Theodrenaline.
Theophylline
The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.
Theophylline anhydrous
The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.
Tibolone
Pentoxifylline may increase the hypotensive activities of Tibolone.
Ticagrelor
Pentoxifylline may increase the antiplatelet activities of Ticagrelor.
Ticlopidine
Pentoxifylline may increase the antiplatelet activities of Ticlopidine.
Timolol
Pentoxifylline may increase the hypotensive activities of Timolol.
Timolol Anhydrous
Pentoxifylline may increase the hypotensive activities of Timolol.
Tinzaparin
Pentoxifylline may increase the anticoagulant activities of Tinzaparin.
Tinzaparin sodium
Pentoxifylline may increase the anticoagulant activities of Tinzaparin.
Tipranavir
Tipranavir may increase the antiplatelet activities of Pentoxifylline.
Tirofiban
Pentoxifylline may increase the antiplatelet activities of Tirofiban.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Pentoxifylline.
Tolazoline
Pentoxifylline may increase the hypotensive activities of Tolazoline.
Torsemide
Pentoxifylline may increase the hypotensive activities of Torasemide.
Tositumomab
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Tositumomab.
Trandolapril
Pentoxifylline may increase the hypotensive activities of Trandolapril.
Tranilast
Pentoxifylline may increase the antiplatelet activities of Tranilast.
Trapidil
Pentoxifylline may increase the antiplatelet activities of Trapidil.
Travoprost
Pentoxifylline may increase the hypotensive activities of Travoprost.
Treprostinil
Pentoxifylline may increase the hypotensive activities of Treprostinil.
Trichlormethiazide
Pentoxifylline may increase the hypotensive activities of Trichlormethiazide.
Triflusal
Pentoxifylline may increase the antiplatelet activities of Triflusal.
Trimethaphan
Pentoxifylline may increase the hypotensive activities of Trimethaphan.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Trolamine salicylate.
Troxerutin
Pentoxifylline may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
Pentoxifylline may increase the hypotensive activities of Unoprostone.
Urapidil
Pentoxifylline may increase the hypotensive activities of Urapidil.
Urokinase
Pentoxifylline may increase the anticoagulant activities of Urokinase.
Valsartan
Pentoxifylline may increase the hypotensive activities of Valsartan.
Vemurafenib
The serum concentration of Pentoxifylline can be increased when it is combined with Vemurafenib.
Vincamine
Pentoxifylline may increase the hypotensive activities of Vincamine.
Vinpocetine
Pentoxifylline may increase the hypotensive activities of Vinpocetine.
Vitamin E
Vitamin E may increase the antiplatelet activities of Pentoxifylline.
Vorapaxar
Pentoxifylline may increase the antiplatelet activities of Vorapaxar.
Warfarin
Pentoxifylline may increase the anticoagulant activities of Warfarin.
Xylometazoline
Pentoxifylline may increase the hypotensive activities of Xylometazoline.
Zofenopril
Pentoxifylline may increase the hypotensive activities of Zofenopril.